1·The fundamental pharmacokinetic processes are dilution into volumes of distribution and clearance.
药代动力学的基本过程分为分配和清除量稀释。
2·OBJECTIVE: to develop a HPLC-UV method to determine the concentration of galanthamine in human plasma and study its pharmacokinetic profiles and bioequivalence.
目的：建立加兰他敏血浆药物浓度的HPLC - UV检测法，研究其在人体的药代动力学和相对生物利用度。
3·Other pharmacokinetic data e. g., results of population studies performed within clinical trial s.
其他药代动力学数据(例如，临床试验进行的人口研究结果)。
4·Conclusion: the method is practical and can be used for the pharmacokinetic study of pravastatin.
结论：方法实用有效，可用于药代动力学研究。
5·Pharmacokinetic Modeling of Tumor Bioluminescence Implicates Efflux, and Not Influx, as the Bigger Hurdle in Cancer Drug Therapy.
肿瘤生物发光交错外流，而非内流，的药代动力学模型成为癌症药物治疗的更大障碍。